Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 5, 2003, Pages 892-897

  Post, Sabine M ^a   De Crom, Rini ^b   Van Haperen, Rien ^b   Van Tol, Arie ^b   Princen, Hans M G ^a  

^a TNO   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bile acid; HDL; Mouse; Phospholipid transfer protein; Reverse cholesterol transport

Indexed keywords

BILE ACID; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; STEROL;

ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BILE FLOW; BILIARY EXCRETION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HUMAN; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL, HDL; FECES; HUMANS; LIPASE; LIPOPROTEIN LIPASE; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHOLIPID TRANSFER PROTEINS; STEROLS;

EID: 0038300441     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000067702.22390.20     Document Type: Article

References (38)

1. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med. 1989;321:1311-1316.
2. Barter PJ, Rye KA. Molecular mechanisms of reverse cholesterol transport. Curr Opin Lipidol. 1996;7:82-87.
3. Tall AR. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J Clin Invest. 1990;86:379-384.
4. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
5. Turley SD, Dietschy JM. Cholesterol metabolism and excretion. In: Arias IM, Jakoby WB, Popper H, Schachter D. Shafritz DA, eds. The Liver: Biology and Pathobiology. New York: Raven Press; 1988:467-492.
6. Princen HMG, Post SM, Twisk J. Regulation of bile acid biosynthesis. Curr Pharmaceut Design. 1997;3:59-84.
7. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry. 1992;31: 4737-4749.
8. Bjorkhem I. Mechanism of degradation of the steroid side chain in the formation of bile acids. J Lipid Res. 1992;33:455-471.
9. Russell DW. Nuclear orphan receptors control cholesterol catabolism. Cell. 1999;97:539-542.
10. Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis. 2001;155:269-281.
11. van Tol A. Phospholipid transfer protein. Curr Opin Lipidol. 2002;13: 135-139.
12. van Haperen R, van Tol A, Vermeulen P, Jauhiainen M, van Gent T, van den BP, Ehnholm S, Grosveld F, van der KA, de Crom R. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol. 2000;20:1082-1088.
13. Foger B, Santamarina-Fojo S, Shamburek RD. Parrot CL, Talley GD, Brewer HBJ. Plasma phospholipid transfer protein: adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J Biol Chem. 1997;272:27393-27400.
14. Ehnholm S, van Dijk KW, van't Hof B, van der ZA, Olkkonen VM, Jauhiainen M, Hofker M, Havekes L, Ehnholm C. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J Lipid Res. 1998;39:1248-1253.
15. Jiang XC, Qin S, Qiao C, Kawano K, Lin M, Skold A, Xiao X, Tall AR. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med. 2001;7:847-852.
16. Jiang XC, Tall AR, Qin S, Lin M, Schneider M, Lalanne F, Deckert V, Desrumaux C, Athias A, Witztum JL, Lagrost L. Phospholipid transfer protein (PLTP) deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem. 2002;277:31850-31856.
17. de Crom R, van Haperen R, van Gent T, Scheek, van der Kamp A, van Tol A. Transgenic mice overexpressing phospholipid transfer protein are less susceptible to diet-induced hypercholesterolemia. Circulation. 2000; 102:46. Abstract.
18. van Haperen R, van Tol A, van Gent T, Scheek L, Visser P, van der Kamp A, Grosveld F, de Crom R. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J Biol Chem. 2002;277: 48938-48943.
19. Strauss JG, Frank S, Kratky D, Hammerle G, Hrzenjak A, Knipping G, von Eckardstein A, Kostner GM, Zechner R. Adenovirus-mediated rescue of lipoprotein lipase-deficient mice: lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J Biol Chem. 2001;276:36083-36090.
20. Post SM, Zoeteweij JP, Bos MH, de Wit EC, Havinga R, Kuipers F, Princen HM. Acyl-coenzyme A: cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alphahydroxylase in cultured rat hepatocytes and in vivo in the rat. Hepatology. 1999;30:491-500.
21. Cohen LH, Griffioen AM, Wanders RJ, Van Roermund CW, Huysmans CM, Princen HM. Regulation of squalene synthetase activity in rat liver: elevation by cholestyramine, but no diurnal variation. Biochem Biophys Res Commun. 1986;138:335-341.
22. Kuipers F, van Ree JM, Hofker MH, Wolters H, In't Veld G, Havinga R, Vonk RJ, Princen HM, Havekes LM. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology. 1996;24:241-247.
23. Bligh EG, Dyer WJ. A rapid method for total lipid extraction and purification. Can J Biochem. 1959;193:135-144.
24. Twisk J, Lehmann EM, Princen HM. Differential feedback regulation of cholesterol 7 alpha-hydroxylase mRNA and transcriptional activity by rat bile acids in primary monolayer cultures of rat hepatocytes. Biochem J. 1993;290(pt 3):685-691.
25. Wilson GN, Hollar BA, Waterson JR, Schmickel RD. Molecular analysis of cloned human 18S ribosomal DNA segments. Proc Natl Acad Sci U S A. 1978;75:5367-5371.
26. Setchell KDR, Worthington J. A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges. Clin Chim Acta. 1982;125:135-144.
27. Volger OL, van der Boom H, de Wit EC, van Duyvenvoorde W, Hornstra G. Plat J, Havekes LM, Mensink RP, Princen HM. Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol. 2001;21:1046-1052.
28. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs HH, Mangelsdorf DJ. Regulation of ATP-binding cassette sterol transporters, ABCG5 and ABCG8, by the oxysterol receptors, LXRalpha and beta. J Biol Chem. 2002;277:18793-18800.
29. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 2000;102:731-744.
30. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res. 1978;19:945-955.
31. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature. 1997;387:414-417.
32. Sehayek E, Ono JG, Shefer S, Nguyen LB, Wang N, Batta AK, Salen G, Smith JD, Tall AR, Breslow JL. Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc Natl Acad Sci U S A. 1998;95:10194-10199.
33. Ito T, Sabol SL, Amar M, Knapper C, Duarte C, Shamburek RD, Meyn S, Santamarina-Fojo S, Brewer B. Adenovirus-mediated expression establishes an in vivo role for human ABCGI (ABC8) in lipoprotein metabolism. Circulation. 2000;102(suppl II):311.
34. Lie J, de Crom R, van Gent T, van Haperen R, Scheek L, Lankhuizen I. van Tol A. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J Lipid Res. 2002;43: 1875-1880.
35. Eriksson M, Carlson LA, Miettinen TA, Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I: potential reverse cholesterol transport in humans. Circulation. 1999;100:594-598.
36. Cao G, Beyer TP, Yang XP, Schmidt RJ, Zhang Y, Bensch WR, Kauffman RF, Gao H, Ryan TP, Liang Y, Eacho PI, Jiang XC. Phospholipid transfer protein is regulated by liver x receptors in vivo. J Biol Chem. 2002;277:39561-39565.
37. Grefhorst A, Elzinga BM, Voshol PJ, Plosch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ, Kuipers F. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem. 2002;277:34182-34190.
38. Plosch T, Kok T, Bloks VW, Smit MJ, Havinga R, Chimini G, Groen AK, Kuipers F. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X-receptor (LXR) is independent of ABCA1. J Biol Chem. 2002;277:33870-33877.